Stay updated on LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial
Sign up to get notified when there's something new on the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page.

Latest updates to the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe footer’s site revision identifier changes from v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedAn NIH-wide notice about terminology changes during the website transition was added, and the site revision changed from v3.7.1 to v3.7.2.SummaryDifference0.4%

- Check36 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check57 days agoChange DetectedA new revision label v3.7.0 was added and the previous v3.6.6 label was removed on the Record History page, indicating a software version update to the page. This change reflects a backend/version update rather than any change to the study record content.SummaryDifference0.1%

- Check71 days agoChange DetectedThe revision history now shows a new release labeled v3.6.6 replacing the previous v3.6.5. This updates the page's version history to reflect the latest update.SummaryDifference0.1%

- Check92 days agoChange DetectedA new revision entry v3.6.5 appears in the study history, replacing the previous v3.6.4. This indicates the record was updated to a new version after QC, without substantive changes to the study information.SummaryDifference0.0%

Stay in the know with updates to LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the LAG525 and Spartalizumab Combination in Advanced TNBC Clinical Trial page.